Rapid Point-of-Care Test for Chlamydia and Gonorrhea
The FDA granted 510(k) clearance to binx io for a women’s health molecular rapid point of care diagnostic testing platform for detecting chlamydia and gonorrhea in about a half hour in August 2019. Image courtesy of binx at https://mybinxhealth.com/clinician-solutions/ The technology platform is a rapid and fully automated test that requires no calibration, no maintenance, and …